Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07216794 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Small Trial of Alendronate Impact on the Reservoir of HIV

Study acronym: STAIR-HIV
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 31 words Secondary endpoints: details revised at 1 of 16 entries · Site details revised at 2 of 5 sites Show 2 more changesShow less
    • Secondary endpoints: details revised at 1 of 16 entries
    • Site details revised at 2 of 5 sites
  2. Recruitment opened Start date changed from estimate of Jun 27, 2026 to Jul 8, 2026 · Site details revised at 5 of 5 sitesv5 Show 2 more changesShow less
    • Start date changed from estimate of Jun 27, 2026 to Jul 8, 2026
    • Site details revised at 5 of 5 sites
  3. 2 versions Re-verified since May 18, 2026, no change to tracked fieldsv3-v4
  4. Start date: Jan 17, 2026 to Jun 27, 2026v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial is designed to test the effects of alendronate (ALN) on people living with HIV who are already receiving antiretroviral therapy (ART). Participants are randomly assigned in a 2:1 ratio to either receive alendronate or a placebo, and neither the participants nor the researchers know who is receiving the actual treatment. The goal is to see if alendronate can reduce the size and activity of the HIV-1 reservoir in these individuals.
Trial Details
NCT Number NCT07216794
Lead Sponsor National Institute of Allergy and Infectious Diseases (NIAID)
Conditions HIV
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov